Everything we've seen

1. ?Nov 13, 2:20 PMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   STE is up 4.07% intraday with no attributable headline, suggesting institutional flow or a catalyst not yet reflected in public news (earnings, guidance, upgrade, deal). A move of this magnitude on a healthcare/sterilization name like STERIS represents real conviction buying. However, several factors temper enthusiasm: (1) 85 minutes remaining is moderate but not ample — enough time to run but also enough for profit-taking to set in after a 4%+ move; (2) the macro backdrop (T10Y2Y at 2σ below trend, flattening curve) is modestly supportive of defensive/healthcare names but not a strong tailwind; (3) no news means we cannot assess whether the catalyst is fully priced in or still being digested; (4) a 4% move in a large-cap healthcare name without news raises the possibility of a fade as algos and opportunistic sellers step in near the highs. On balance, momentum is real and the asymmetric stop/target structure favors taking the trade, but conviction is modest — no clear reason to expect a strong fade, but no compelling continuation signal either.

2. !Nov 13, 2:20 PMsignalseverity 0.04

   Agent 7 — Day Trader — day_trade_skipped

   STE is up 4.07% intraday with no attributable headline, suggesting institutional flow or a catalyst not yet reflected in public news (earnings, guidance, upgrade, deal). A move of this magnitude on a healthcare/sterilization name like STERIS represents real conviction buying. However, several factors temper enthusiasm: (1) 85 minutes remaining is moderate but not ample — enough time to run but also enough for profit-taking to set in after a 4%+ move; (2) the macro backdrop (T10Y2Y at 2σ below trend, flattening curve) is modestly supportive of defensive/healthcare names but not a strong tailwind; (3) no news means we cannot assess whether the catalyst is fully priced in or still being digested; (4) a 4% move in a large-cap healthcare name without news raises the possibility of a fade as algos and opportunistic sellers step in near the highs. On balance, momentum is real and the asymmetric stop/target structure favors taking the trade, but conviction is modest — no clear reason to expect a strong fade, but no compelling continuation signal either.

3. ?Nov 13, 12:40 PMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   STE is up 3.84% intraday with no headline catalyst visible, suggesting this is institutionally driven flow rather than a news-spike that could quickly reverse. The move has real conviction behind it. However, several factors temper enthusiasm for strong continuation: (1) At 3.84%, the move is already approaching the upper bound of the 2-5% 'meaningful' range, meaning much of the gap has already been captured and the profit target (+3% from entry) would require pushing STE toward ~$271, a level that may face sellers. (2) 185 minutes remaining is ample time for continuation but also for mean-reversion if no fresh catalyst emerges. (3) The macro context (T10Y2Y at 2.0σ below trend, bear-flattening signal) is modestly supportive for defensive/healthcare names like STE, as flatter yield curves tend to rotate capital toward quality defensives — a mild tailwind. (4) No reversal pattern or fade signal is evident from the data provided. Overall, this is a borderline-to-modest continuation setup. The macro backdrop provides a slight supportive tilt for a healthcare/med-device name like Steris, and the absence of a news-driven spike reduces the risk of a sharp snap-back. Assigning a modest continuation probability just above the action threshold.

4. !Nov 13, 12:40 PMsignalseverity 0.04

   Agent 7 — Day Trader — day_trade_skipped

   STE is up 3.84% intraday with no headline catalyst visible, suggesting this is institutionally driven flow rather than a news-spike that could quickly reverse. The move has real conviction behind it. However, several factors temper enthusiasm for strong continuation: (1) At 3.84%, the move is already approaching the upper bound of the 2-5% 'meaningful' range, meaning much of the gap has already been captured and the profit target (+3% from entry) would require pushing STE toward ~$271, a level that may face sellers. (2) 185 minutes remaining is ample time for continuation but also for mean-reversion if no fresh catalyst emerges. (3) The macro context (T10Y2Y at 2.0σ below trend, bear-flattening signal) is modestly supportive for defensive/healthcare names like STE, as flatter yield curves tend to rotate capital toward quality defensives — a mild tailwind. (4) No reversal pattern or fade signal is evident from the data provided. Overall, this is a borderline-to-modest continuation setup. The macro backdrop provides a slight supportive tilt for a healthcare/med-device name like Steris, and the absence of a news-driven spike reduces the risk of a sharp snap-back. Assigning a modest continuation probability just above the action threshold.

5. ?Nov 13, 10:55 AMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   STE is up ~4% intraday with no attributable headline, suggesting institutional flow or possibly a delayed reaction to earnings/guidance. A 4% move with no news is meaningful — real size moved this. However, several factors temper enthusiasm: (1) 290 minutes remaining is actually substantial time, but with no catalyst to anchor the move, late-session profit-taking is a real risk; (2) the macro backdrop shows a T10Y2Y spread 2σ below trend, which is mildly supportive of defensives like STE (medical device/sterilization is a defensive-leaning sector), but not a strong tailwind; (3) absence of news cuts both ways — no fresh catalyst to drive further buying into the close, but also no negative overhang. STE is a low-beta, steady-compounder type name, which means large intraday moves tend to be driven by earnings or guidance surprises that sustain. Without confirmation of that, there is some fade risk as the move may have already captured the bulk of the flow. On balance, the momentum is real and the macro context is not adverse, but conviction for strong continuation is limited. Assigning a modest continuation probability above 0.5.

6. !Nov 13, 10:55 AMsignalseverity 0.04

   Agent 7 — Day Trader — day_trade_skipped

   STE is up ~4% intraday with no attributable headline, suggesting institutional flow or possibly a delayed reaction to earnings/guidance. A 4% move with no news is meaningful — real size moved this. However, several factors temper enthusiasm: (1) 290 minutes remaining is actually substantial time, but with no catalyst to anchor the move, late-session profit-taking is a real risk; (2) the macro backdrop shows a T10Y2Y spread 2σ below trend, which is mildly supportive of defensives like STE (medical device/sterilization is a defensive-leaning sector), but not a strong tailwind; (3) absence of news cuts both ways — no fresh catalyst to drive further buying into the close, but also no negative overhang. STE is a low-beta, steady-compounder type name, which means large intraday moves tend to be driven by earnings or guidance surprises that sustain. Without confirmation of that, there is some fade risk as the move may have already captured the bulk of the flow. On balance, the momentum is real and the macro context is not adverse, but conviction for strong continuation is limited. Assigning a modest continuation probability above 0.5.

7. ?Nov 13, 9:40 AMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   STE is up 2.36% intraday with no attributable headline, suggesting institutional flow or sector rotation into this defensive/healthcare name. With 365 minutes remaining (over 6 hours — likely meaning this is early in the session), there is ample time for the move to extend. The macro context shows the 10Y2Y spread at 0.24, 2 sigma below trend, which is a mild bear-flattening signal favoring defensives — STE as a healthcare/sterilization services company fits the defensive profile that benefits in this environment. No reversal signals or fade patterns are evident from the data provided. No news creates uncertainty about the catalyst, but the magnitude of the move (2.36%) reflects real conviction from size players. Given the supportive macro tilt toward defensives, time remaining, and absence of any fade signal, a modest continuation probability is warranted. No strong accelerant pushes this above 0.65, so settling at 0.54 reflects ordinary momentum with a modestly supportive macro backdrop.

8. !Nov 13, 9:40 AMsignalseverity 0.02

   Agent 7 — Day Trader — day_trade_skipped

   STE is up 2.36% intraday with no attributable headline, suggesting institutional flow or sector rotation into this defensive/healthcare name. With 365 minutes remaining (over 6 hours — likely meaning this is early in the session), there is ample time for the move to extend. The macro context shows the 10Y2Y spread at 0.24, 2 sigma below trend, which is a mild bear-flattening signal favoring defensives — STE as a healthcare/sterilization services company fits the defensive profile that benefits in this environment. No reversal signals or fade patterns are evident from the data provided. No news creates uncertainty about the catalyst, but the magnitude of the move (2.36%) reflects real conviction from size players. Given the supportive macro tilt toward defensives, time remaining, and absence of any fade signal, a modest continuation probability is warranted. No strong accelerant pushes this above 0.65, so settling at 0.54 reflects ordinary momentum with a modestly supportive macro backdrop.

9. ?Nov 9, 3:00 PMdecisionconsidered

   Agent 7 — Day Trader — decide: skip

   STE is up 2.32% intraday with no attributable headline, suggesting this is either a delayed reaction to something earlier in the week or a technical/flow-driven move. The macro context (elevated mortgage rates at 7.18%, 1.9σ above trend) is not directly relevant to STE, a medical device/sterilization services company, so there is no macro headwind or tailwind to factor in. The move itself is meaningful and represents real conviction. However, with only 45 minutes remaining until the forced close, the window for further continuation is narrow. At this stage of the session, intraday momentum plays are increasingly at risk of profit-taking and mean reversion as participants lock in gains. The absence of a catalyst also makes it harder to argue for sustained buying pressure into the close — without a news driver to anchor bulls, late-day sellers may fade the move. The magnitude (2.32%) is at the lower end of the 'meaningful' range and doesn't scream extreme conviction. On balance, the combination of limited time remaining and no identifiable catalyst tilts the probability just below the 0.5 threshold, making this a pass.

10. !Nov 9, 3:00 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    STE is up 2.32% intraday with no attributable headline, suggesting this is either a delayed reaction to something earlier in the week or a technical/flow-driven move. The macro context (elevated mortgage rates at 7.18%, 1.9σ above trend) is not directly relevant to STE, a medical device/sterilization services company, so there is no macro headwind or tailwind to factor in. The move itself is meaningful and represents real conviction. However, with only 45 minutes remaining until the forced close, the window for further continuation is narrow. At this stage of the session, intraday momentum plays are increasingly at risk of profit-taking and mean reversion as participants lock in gains. The absence of a catalyst also makes it harder to argue for sustained buying pressure into the close — without a news driver to anchor bulls, late-day sellers may fade the move. The magnitude (2.32%) is at the lower end of the 'meaningful' range and doesn't scream extreme conviction. On balance, the combination of limited time remaining and no identifiable catalyst tilts the probability just below the 0.5 threshold, making this a pass.

11. ?Nov 5, 9:36 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 1.53% today with no headline catalyst identified, suggesting this is flow-driven rather than news-driven. The move is modest — below the 2-5% threshold that would indicate high conviction institutional activity — so it carries limited inherent momentum signal on its own. Macro context shows the fed funds rate printing 2.1σ above its 24-month trend, which is modestly negative for rate-sensitive equities broadly, but STE (Steris, a medical device/services company) has limited direct sensitivity to money-market or banking sector dynamics, so the macro headwind is minimal rather than material. With 370 minutes remaining (session just getting started mid-morning equivalent), there is ample time for the move to extend, which is a mild positive. No reversal signals or fade patterns are evident from the data provided. The absence of news does not disqualify continuation. Net assessment: weak-to-neutral momentum with no strong countervailing force, warranting a marginal continuation call aligned with the system's bias toward action when no clear fade reason exists.

12. !Nov 5, 9:36 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    STE is up 1.53% today with no headline catalyst identified, suggesting this is flow-driven rather than news-driven. The move is modest — below the 2-5% threshold that would indicate high conviction institutional activity — so it carries limited inherent momentum signal on its own. Macro context shows the fed funds rate printing 2.1σ above its 24-month trend, which is modestly negative for rate-sensitive equities broadly, but STE (Steris, a medical device/services company) has limited direct sensitivity to money-market or banking sector dynamics, so the macro headwind is minimal rather than material. With 370 minutes remaining (session just getting started mid-morning equivalent), there is ample time for the move to extend, which is a mild positive. No reversal signals or fade patterns are evident from the data provided. The absence of news does not disqualify continuation. Net assessment: weak-to-neutral momentum with no strong countervailing force, warranting a marginal continuation call aligned with the system's bias toward action when no clear fade reason exists.

13. ?Oct 21, 6:21 PMdecisionconsidered

    Agent 20 — SIR Price/Volume — skip

    [exhaustion] The 20-day PV path traced a constructive accumulation arc from the $208–$211 cluster (Sep 24–Oct 7) up through a strong breakout leg that peaked at $225.18 on Oct 20 — a clean up-and-right drift. However, today's bar (Oct 21) delivers a volume spike of 1.8M against a 20-day ADV of just 606K (z-score: 9.12), while the close dropped -1.64% to $221.48 — a price extreme on an unprecedented volume surge. This single-session combination of maximum volume at a price peak with a down-close is the textbook SIR exhaustion signature: the most recent dot is simultaneously a volume outlier AND a price-range extreme relative to the prior cluster, suggesting climactic selling into prior demand. Applying the macro rule, the 2y yield at 4.77 (2.1σ above trend) represents a genuine macro headwind for rate-sensitive equities that adds weight to the exhaustion read, though macro context noted is not a broad bull-regime confirmation. Risks: This read would be invalidated if the next 1–2 sessions reclaim $224+ on moderate volume, which would reframe today's bar as a shakeout/reversal day within a continuing accumulation path rather than a climax top. Additionally, if sector-wide selling in Health Care drove abnormal volume rather than STE-specific distribution, the exhaustion signal loses idiosyncratic force.

14. ?Oct 12, 12:00 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.54% intraday with no attributable headline, suggesting this is flow-driven rather than news-driven. The move is meaningful in magnitude and represents real conviction from institutional-sized participation. However, several factors temper the continuation case: (1) No news catalyst means there is no ongoing narrative to sustain buying pressure into the close. (2) The macro context shows T10Y3M at 1.6σ above trend — a steepening yield curve that tends to benefit banks but is broadly neutral-to-mildly negative for healthcare/medtech names like STE (Steris plc), as higher long rates can pressure valuations on steady-growth defensive equities. (3) 225 minutes remaining is ample time for either continuation or a fade, so time is not a constraining factor cutting against the trade. (4) Without reversal signals or volume data flagging abnormal lightness, there is no strong reason to expect a fade. On balance, this is an ordinary momentum read — a real move with no clear fade catalyst but also no strong continuation catalyst. Assigning a modest continuation probability just above the trigger threshold.

15. !Oct 12, 12:00 PMsignalseverity 0.03

    Agent 7 — Day Trader — day_trade_skipped

    STE is up 2.54% intraday with no attributable headline, suggesting this is flow-driven rather than news-driven. The move is meaningful in magnitude and represents real conviction from institutional-sized participation. However, several factors temper the continuation case: (1) No news catalyst means there is no ongoing narrative to sustain buying pressure into the close. (2) The macro context shows T10Y3M at 1.6σ above trend — a steepening yield curve that tends to benefit banks but is broadly neutral-to-mildly negative for healthcare/medtech names like STE (Steris plc), as higher long rates can pressure valuations on steady-growth defensive equities. (3) 225 minutes remaining is ample time for either continuation or a fade, so time is not a constraining factor cutting against the trade. (4) Without reversal signals or volume data flagging abnormal lightness, there is no strong reason to expect a fade. On balance, this is an ordinary momentum read — a real move with no clear fade catalyst but also no strong continuation catalyst. Assigning a modest continuation probability just above the trigger threshold.

16. ?Oct 12, 10:55 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE is up 2.21% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news spike that might fade. The move is meaningful but not extreme. Macro context shows T10Y3M at 0.99 (1.6σ above trend), which is modestly supportive of quality defensive names like STE (medical device/sterilization sector) as yield curve normalization can benefit non-bank, recession-resilient businesses. With 290 minutes remaining (approximately 4h50m), there is ample time for continuation. No reversal signals noted — absence of news does not disqualify the trade, and the move appears to reflect genuine conviction buying. The setup is ordinary momentum without strong tailwinds to push to high-conviction territory, so probability sits in the 0.50–0.65 range. Taking the continuation trade is appropriate given bounded downside (-1.5% stop) and asymmetric reward (+3% target).

17. !Oct 12, 10:55 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    STE is up 2.21% today with no attributable headline, suggesting institutional flow or sector rotation rather than a news spike that might fade. The move is meaningful but not extreme. Macro context shows T10Y3M at 0.99 (1.6σ above trend), which is modestly supportive of quality defensive names like STE (medical device/sterilization sector) as yield curve normalization can benefit non-bank, recession-resilient businesses. With 290 minutes remaining (approximately 4h50m), there is ample time for continuation. No reversal signals noted — absence of news does not disqualify the trade, and the move appears to reflect genuine conviction buying. The setup is ordinary momentum without strong tailwinds to push to high-conviction territory, so probability sits in the 0.50–0.65 range. Taking the continuation trade is appropriate given bounded downside (-1.5% stop) and asymmetric reward (+3% target).

18. ?Oct 9, 3:15 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    STE (Steris) is up 2.16% intraday with no attributable news catalyst. The move represents real buying flow, but with only 30 minutes remaining until the forced 3:45 PM ET close, there is very limited time for continuation to reach the +3% profit target. The macro context (elevated mortgage rates at 3.8σ above trend) is not directly relevant to STE as a medical device/sterilization services company, so no meaningful macro tailwind or headwind applies. With 30 minutes left, the stock would need to add another ~0.84% to hit target, which is achievable but the short window compresses the probability. Late-session profit-taking is a real risk after a ~$4.56 move on no news. The combination of very limited time remaining and absence of any identifiable catalyst driving further urgency pushes the probability just below the 0.5 threshold — not because the move lacks conviction, but because the reward/time ratio is unfavorable with a hard 3:45 flatten.

19. !Oct 9, 3:15 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    STE (Steris) is up 2.16% intraday with no attributable news catalyst. The move represents real buying flow, but with only 30 minutes remaining until the forced 3:45 PM ET close, there is very limited time for continuation to reach the +3% profit target. The macro context (elevated mortgage rates at 3.8σ above trend) is not directly relevant to STE as a medical device/sterilization services company, so no meaningful macro tailwind or headwind applies. With 30 minutes left, the stock would need to add another ~0.84% to hit target, which is achievable but the short window compresses the probability. Late-session profit-taking is a real risk after a ~$4.56 move on no news. The combination of very limited time remaining and absence of any identifiable catalyst driving further urgency pushes the probability just below the 0.5 threshold — not because the move lacks conviction, but because the reward/time ratio is unfavorable with a hard 3:45 flatten.

20. ?Oct 9, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

21. !Oct 9, 7:00 AMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

22. ?Oct 9, 7:00 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

23. !Oct 9, 7:00 AMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

24. ?Oct 8, 6:02 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

25. !Oct 8, 6:02 PMsignalseverity 0.11

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

26. ?Oct 8, 4:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

27. !Oct 8, 4:20 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

28. ?Oct 8, 4:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

29. !Oct 8, 4:20 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

30. ?Oct 8, 3:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

31. ?Oct 8, 3:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

32. !Oct 8, 3:21 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

33. !Oct 8, 3:21 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

34. ?Oct 8, 2:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

35. !Oct 8, 2:20 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

36. ?Oct 8, 2:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

37. !Oct 8, 2:20 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

38. ?Oct 8, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

39. !Oct 8, 1:20 PMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

40. ?Oct 8, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

41. !Oct 8, 1:20 PMsignalseverity 0.11

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

42. ?Oct 8, 12:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

43. !Oct 8, 12:20 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

44. ?Oct 8, 12:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

45. !Oct 8, 12:20 PMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

46. ?Oct 8, 11:21 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

47. !Oct 8, 11:21 AMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

48. ?Oct 8, 11:21 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

49. !Oct 8, 11:21 AMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

50. ?Oct 8, 10:20 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

51. !Oct 8, 10:20 AMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

52. ?Oct 8, 10:20 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

53. !Oct 8, 10:20 AMsignalseverity 0.11

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

54. ?Oct 8, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

55. !Oct 8, 7:00 AMsignalseverity 0.12

    Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

56. ?Oct 8, 7:00 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

57. !Oct 8, 7:00 AMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

58. ?Oct 7, 6:02 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

59. !Oct 7, 6:02 PMsignalseverity 0.12

    Agent 4 — Dip Buyer (Frozen) — dip_skipped

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

60. ?Oct 7, 4:21 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

61. !Oct 7, 4:21 PMsignalseverity 0.12

    Agent 5 — Dip Buyer (Evolving) — dip_skipped

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

62. ?Oct 7, 4:21 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

63. ?Oct 7, 3:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

64. ?Oct 7, 3:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

65. ?Oct 7, 2:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

66. ?Oct 7, 2:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

67. ?Oct 7, 1:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

68. ?Oct 7, 1:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

69. ?Oct 7, 12:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

70. ?Oct 7, 12:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

71. ?Oct 7, 11:21 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

72. ?Oct 7, 11:21 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

73. ?Oct 7, 10:21 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

74. ?Oct 7, 10:21 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

75. ?Oct 7, 7:00 AMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

76. ?Oct 7, 7:00 AMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

77. ?Oct 6, 6:02 PMdecisionconsidered

    Agent 4 — Dip Buyer (Frozen) — decide: skip

    STERIS (STE) is a well-established medical device and sterilization services company with historically stable cash flows and a defensive business model, and there are no visible company-specific negative catalysts — no guidance cuts, accounting issues, or sector collapse — in the available SEC filings or news window. The 12.7% drawdown from its 30-day high appears to be macro-driven rather than fundamental deterioration, likely reflecting rate sensitivity as the 5-year forward inflation rate (T5YIFR) is running 1.8σ above its 24-month trend, pressuring rate-sensitive equities broadly. Given the absence of negative company-specific news and STE's defensive positioning, a partial mean-reversion toward the 30-day high within 90 days is plausible, though elevated rate expectations introduce a headwind.

78. ?Oct 6, 4:20 PMdecisionconsidered

    Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

    STE (STERIS plc) is a well-established healthcare equipment/sterilization company with a 13.1% pullback from its 30-day high — a moderate dip with no confirmed fundamental catalyst in the evidence. No news headlines, no insider buying, and no options flow are available to explain or confirm the drop, leaving the cause unclear (possibly macro/sector-driven or routine profit-taking). The healthcare sector (XLV) is actually outperforming SPY over both the 5-day and 30-day windows (+1.54pts), suggesting this is idiosyncratic weakness rather than sector-wide selling — which warrants some caution about company-specific risk. Earnings are 39 days out, a non-urgent but notable binary event on the horizon. The 10Y at 5.11% is a structural headwind for rate-sensitive healthcare names, and T5YIFR is elevated at 1.6σ above trend, adding a modest macro drag. Without confirmation signals (no insider buys, no call flow) and with the sector outperforming while STE underperforms, this sits in the weak/neutral evidence bucket with limited conviction for a meaningful rebound.

79. ?Oct 6, 4:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.

80. ?Oct 6, 3:20 PMdecisionconsidered

    Agent 5 — Dip Buyer (Evolving) — decide: skip

    STE (STERIS plc) is a defensive healthcare infrastructure name (sterilization/surgical equipment) with no fundamental deterioration evident in recent filings — the 10-Q and 8-Ks carry no reported guidance cuts, going-concern language, or covenant issues, and metrics fields are empty suggesting no red flags surfaced. The ~10.9% dip is below the +1 signal threshold of ≥15%, and Health Care (XLV) is underperforming SPY on both 5-day and 30-day bases (-1.86pts and -1.35pts respectively), suggesting this is largely a sector-rotation/macro drag rather than a single-stock idiosyncratic problem. Net signal score lands near 0: sector underperformance (+1), no insider cluster buy or unusual call flow (0), drop <15% (0), earnings 55 days away and beyond 30-day window (+1), but 10Y at 4.78% is a structural headwind even for a semi-defensive name (-1) and forward 5Y inflation breakeven running 1.8σ above trend adds rate-sensitivity risk (-1), yielding a net score of ~0.